Stockscreener 앱 받기
0.15%
전일 마감가:
$26.03
열려 있는:
$26.04
하루 거래량:
15.23M
Relative Volume:
0.23
시가총액:
$148.00B
수익:
$62.79B
순이익/손실:
$9.84B
주가수익비율:
15.15
EPS:
1.7156
순현금흐름:
$10.38B
1주 성능:
+2.85%
1개월 성능:
+6.39%
6개월 성능:
+11.31%
1년 성능:
+1.01%
1일 변동 폭
$25.79
$26.13
1주일 범위
$25.04
$26.13
52주 변동 폭
$20.91
$27.69
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
PFE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
26.03 | 148.00B | 62.79B | 9.84B | 10.38B | 1.7156 |
|
LLY
Lilly Eli Co
|
993.99 | 904.25B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
203.11 | 486.51B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
225.19 | 399.57B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
131.96 | 253.59B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
99.36 | 247.51B | 63.90B | 19.05B | 13.05B | 7.5596 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Citigroup | Neutral |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Pfizer (PFE) Stock: AI Cost-Cutting and Strong Dividend Attract Investors - parameter.io
How Do Investors Really Feel About Pfizer Inc? - Benzinga
Natixis Has $45.97 Million Stock Holdings in Pfizer Inc. $PFE - MarketBeat
SVB Wealth LLC Invests $4.07 Million in Pfizer Inc. $PFE - MarketBeat
Pfizer Says Hympavzi Reduced Bleeds by 93% Compared With On-Demand Treatment in Phase-3 Study - marketscreener.com
Ossiam Boosts Stock Position in Pfizer Inc. $PFE - MarketBeat
StoneX Group Inc. Lowers Holdings in Pfizer Inc. $PFE - MarketBeat
Gamco Investors INC. ET AL Trims Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Eli Lilly, Pfizer Feature in China's Commercial Insurance Innovative Drug Catalog - marketscreener.com
Pfizer (PFE) Reports Positive Phase 3 Results for Hemophilia Tre - GuruFocus
Pfizer’s HYMPAVZI shows superior bleeding control in hemophilia phase 3 study (PFE:NYSE) - Seeking Alpha
Eli Lilly, Pfizer Land on China’s First Private Insurance List - Bloomberg.com
Pfizer (PFE) Reports Positive Phase 3 Study Results for HYMPAVZI - GuruFocus
Autism Spectrum Disorder Market to Reach USD 4.07 Billion by 2033, Driven by Rising Awareness, Early Diagnosis & Advances in Personalized Therapeutics | SNS Insider - GlobeNewswire Inc.
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - GlobeNewswire Inc.
Pfizer (PFE) Stock; Rises on Strong Dividend Yield and Low Valuation Debate - CoinCentral
Federated Hermes Inc. Raises Stock Position in Pfizer Inc. $PFE - MarketBeat
Eli Lilly, Pfizer land on China’s first private insurance list - The Edge Malaysia
Eli Lilly, Pfizer Secure Inclusion in Chinese Private Health Insurance Catalog - marketscreener.com
Pfizer Inc. Presents Results from the Phase 3 BASIS Study Evaluating HYMPAVZI for Adults and Adolescents - marketscreener.com
Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue - Yahoo Finance
Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - GlobeNewswire Inc.
US717081FH1 Bond Price and Chart — DUS:US717081FH1 - TradingView
Pfizer Inc. $PFE Holdings Lowered by Panagora Asset Management Inc. - MarketBeat
Cresset Asset Management LLC Boosts Stake in Pfizer Inc. $PFE - MarketBeat
Can Pfizer’s Recent Recovery Signal a Long Term Value Opportunity in 2025? - Yahoo Finance
1832 Asset Management L.P. Has $4.89 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Secures Long-Term Capital with $1.25 Billion Bond Offering - AD HOC NEWS
GSK takes over entire building in Cambridge - The Business Journals
Sandoz, Pfizer Denied Bid to End Generic Drug Price-Fixing Case - Bloomberg Law News
2 Headwinds Facing Pfizer Stock Going Into 2026 - Finviz
Pfizer: The Market Is Still Wrong About It (NYSE:PFE) - Seeking Alpha
3 Reasons PFE is Risky and 1 Stock to Buy Instead - Finviz
Baird Financial Group Inc. Sells 406,942 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Stock Holdings Cut by Amundi - MarketBeat
How Does Pfizer Stock Stack Up Against Its Peers? - Trefis
Pfizer Inc. (PFE): A Bull Case Theory - Insider Monkey
Is Pfizer Stock A Buy After It Clinches The $10 Billion Takeover Of Metsera? - Investor's Business Daily
Pharmaceutical Marketing Industry Trends and Emerging Opportunities 2025-2032 Featuring Syneos Health, McCann Health, Amgen, AXPIRA, Pfizer and MoreResearchAndMarkets.com - The AI Journal
Pfizer (PFE) Up 3.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Bio/Pharmaceutical Outsourcing Report, October 2025Pfizer and Roche Place $10 Billion Bets on Obesity and Liver Disease Therapies as Trump Tightens Grip on Drug Pricing and Manufacturing - Yahoo Finance
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (December 2025) - 24/7 Wall St.
Pfizer Inc. $PFE Stock Holdings Cut by Invesco Ltd. - MarketBeat
Could This Fuel The Next Surge in Pfizer Stock - Trefis
Pharmacy Market size to cross $3.4 Trillion by 2035 | Pfizer Inc., - openPR.com
Pfizer-backed biotech lands $120M, plus other Boston-area life science news - The Business Journals
Jim Cramer on Pfizer: "I would hold on to it" - MSN
Jim Cramer on Pfizer: “I Would Hold on to It” - Insider Monkey
Jim Cramer on Pfizer: "I Would Hold on to It" - Finviz
Does PADCEV Keytruda Bladder Cancer Win Reshape The Bull Case For Pfizer (PFE)? - simplywall.st
Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025) - ts2.tech
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
2.05%
자본화:
|
볼륨(24시간):